Cargando…
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
BACKGROUND/AIMS: Disease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. METHODS: We assessed...
Autores principales: | Park, Jung Eun, Choi, Kyu Yeong, Kim, Byeong C., Choi, Seong-Min, Song, Min-Kyung, Lee, Jang Jae, Kim, Jahae, Song, Ho-Chun, Kim, Hoo-Won, Ha, Jung-Min, Seo, Eun Hyun, Song, Woo Keun, Park, Sung-Gyoo, Lee, Jung Sup, Lee, Kun Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465729/ https://www.ncbi.nlm.nih.gov/pubmed/31011328 http://dx.doi.org/10.1159/000496920 |
Ejemplares similares
-
Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022) -
Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment
por: Lee, Sun Hyung, et al.
Publicado: (2020) -
High-throughput epitope profiling of antibodies in the plasma of Alzheimer’s disease patients using random peptide microarrays
por: Sim, Kyu-Young, et al.
Publicado: (2019) -
Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
por: Sim, Kyu-Young, et al.
Publicado: (2022) -
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography
por: Kim, Jae-Gyum, et al.
Publicado: (2022)